docetaxel anhydrous has been researched along with Bone Marrow Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Ji, Q; Liu, B; Liu, D; Liu, M; Yang, Q; Yang, Z; Zhang, B; Zhou, S | 1 |
| Bissery, MC; Filipski, E; Granda, TG; Lévi, F; Vrignaud, P | 1 |
| Adamson, PC; Franklin, JL; Fu, C; Krailo, M; Reaman, G; Seibel, NL | 1 |
| Miller, KD; Sledge, GW | 1 |
| Bruckner, HW; Kozuch, P; Petryk, M | 1 |
2 review(s) available for docetaxel anhydrous and Bone Marrow Diseases
| Article | Year |
|---|---|
Taxanes in the treatment of breast cancer: a prodigy comes of age.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Metastasis; Neoplasm Proteins; Paclitaxel; Palliative Care; Survival Analysis; Taxoids; Tubulin; Vinca Alkaloids | 1999 |
A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Camptothecin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Enzyme Inhibitors; Epirubicin; Fluorouracil; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Interferon alpha-2; Interferon-alpha; Irinotecan; Leucovorin; Multicenter Studies as Topic; Organoplatinum Compounds; Paclitaxel; Palliative Care; Pancreatic Neoplasms; Recombinant Proteins; Respiratory Distress Syndrome; Taxoids; Treatment Outcome | 2002 |
1 trial(s) available for docetaxel anhydrous and Bone Marrow Diseases
| Article | Year |
|---|---|
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Bone Marrow Diseases; Child; Child, Preschool; Docetaxel; Drug Administration Schedule; Female; Fever; Humans; Infant; Infusions, Intravenous; Leukemia; Leukemia, Myeloid; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Taxoids; Treatment Failure | 2008 |
2 other study(ies) available for docetaxel anhydrous and Bone Marrow Diseases
| Article | Year |
|---|---|
Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.
Topics: Bone Marrow Diseases; Bone Neoplasms; Calcium Phosphates; Cell Line, Tumor; Docetaxel; Humans; Immunosuppression Therapy; Micelles; Osteolysis; Triple Negative Breast Neoplasms; Tumor Microenvironment; Zoledronic Acid | 2023 |
[Rhythm of expression of BCL-2 protein of MA13/C mammaryadenocarcinoma bearing-mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Bone Marrow; Bone Marrow Diseases; Chronotherapy; Circadian Rhythm; Docetaxel; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Proteins; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; Taxoids | 2003 |